caVos Biotherapeutics

caVos Biotherapeutics Overview

Cavos Biotech is developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found across various and specific animals. Harnessing the latest in data and genomics, the company uses high-resolution identification methods to uncover existing anti-cancer mechanisms and novel drug targets in order to revolutionize the way drug targets are discovered and identified.

Cumulative Funding Raised Over Time ($)

Latest News

Nov 13, 2024 · www.themarker.com

growth-positive

תכונות־על מהטבע: הסטארט־אפ הישראלי קאבוס מנסה להעתיק את הפתרונות האבולוציוניים של בעלי החיים

The Israeli startup קאבוס is exploring the genetic mechanisms behind unique animal abilities to develop innovative treatments for humans. The company has recently completed a funding round, raising $3.3 million. This investment is aimed at advancing their research and development efforts. קאבוס focuses on translating evolutionary solutions found in nature into medical applications, potentially revolutionizing healthcare by mimicking traits such as cancer resistance and muscle preservation during hibernation. The funding will support their mission to harness these natural phenomena for human benefit.

Investment

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Jerusalem, Israel

Photos & Videos

No files yet

caVos Biotherapeutics Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info